pentavac (εμβολιο) inj.susp 0,5ml (1dose)
sanofi pasteur europe, france 14 espace henry vallee, 69007 lyon +33 437 28 40 00 - purified tetanus toxoid; purified diphteria toxoid; purified pertussis toxoid (pt xd); filamentous haemagglutinin (fha); inactivated poliovirus vacc type i; inactivated poliovirus vacc type ii; inactivated poliovirus vacc type iii; haemophilus type b polysac. conjugated to tetanus protein - inj.susp (ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ); pd.inj.sus (ΚΟΝΙΣ ΓΙΑ ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ) - 0,5ml (1dose) - purified tetanus toxoid 40iu; purified diphteria toxoid 20iu; purified pertussis toxoid (pt xd) 25mcg; filamentous haemagglutinin (fha) 25mcg; inactivated poliovirus vacc type i 29u; inactivated poliovirus vacc type ii 7u; inactivated poliovirus vacc type iii 26u; haemophilus type b polysac. conjugated to tetanus protein 10mcg - diphtheria-hemophilus influenzae b-pertussis-poliomyelitis-tetanus
infanrix ipv hib (πενταπλου εμβολιο) pd.su.in.s
glaxosmithkline ΜΟΝΟΠΡΟΣΩΠΗ ΑΝΩΝΥΜΗ ΕΜΠΟΡΙΚΗ ΚΑΙ ΒΙΟΜΗΧΑΝΙΚΗ ΕΤΑΙΡΕΙΑ ΦΑΡΜΑΚΕΥΤΙΚΩΝ ΠΡΟΪΟΝΤΩΝ Δ.Τ. glaxosmithkline ΜΟΝΟΠΡΟΣΩΠΗ Α.Ε.Β.Ε. Λεωφ. Κηφισίας 266,, 152 32 152 32, Χαλάνδρι 210-6882100 - pertussis toxoid (pt); filamentous haemagglutinin (fha); pertactin (69 kda outer membrane protein-69k); diphtheria toxoid, adsorbed; tetanus toxoid; inactivated poliovirus vacc type i; inactivated poliovirus vacc type ii; inactivated poliovirus vacc type iii; conjugate of haemophilus influenzae type b capsular polysaccharide(prp) and tetanus toxoid - pd.su.in.s (ΚΟΝΙΣ ΚΑΙ ΕΝΑΙΩΡΗΜΑ ΓΙΑ ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ) - pertussis toxoid (pt) 25mcg; filamentous haemagglutinin (fha) 25mcg; pertactin (69 kda outer membrane protein-69k) 8mcg; diphtheria toxoid, adsorbed 0 => 30iu; tetanus toxoid 0 => 40iu; inactivated poliovirus vacc type i 40du; inactivated poliovirus vacc type ii 8du; inactivated poliovirus vacc type iii 32du; conjugate of haemophilus influenzae type b capsular polysaccharide(prp) and tetanus toxoid 10mcg - hemophilus influenzae b, purified antigen conjugated; diphtheria-hemophilus influenzae b-pertussis-poliomyelitis-tetanus
boostrix inj.su.pfs 0,5ml/pf.syr.(1dose)
glaxosmithkline ΜΟΝΟΠΡΟΣΩΠΗ ΑΝΩΝΥΜΗ ΕΜΠΟΡΙΚΗ ΚΑΙ ΒΙΟΜΗΧΑΝΙΚΗ ΕΤΑΙΡΕΙΑ ΦΑΡΜΑΚΕΥΤΙΚΩΝ ΠΡΟΪΟΝΤΩΝ Δ.Τ. glaxosmithkline ΜΟΝΟΠΡΟΣΩΠΗ Α.Ε.Β.Ε. Λεωφ. Κηφισίας 266,, 152 32 152 32, Χαλάνδρι 210-6882100 - diphtheria toxoid, adsorbed; tetanus toxoid; pertussis toxoid (pt); filamentous haemagglutinin (fha); pertactin (69 kda outer membrane protein-69k) - inj.su.pfs (ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ ΣΕ ΠΡΟΓΕΜΙΣΜΕΝΗ ΣΥΡΙΓΓΑ) - 0,5ml/pf.syr.(1dose) - diphtheria toxoid, adsorbed 0 => 2iu; tetanus toxoid 0 => 20iu; pertussis toxoid (pt) 8mcg; filamentous haemagglutinin (fha) 8mcg; pertactin (69 kda outer membrane protein-69k) 2,5mcg - pertussis, purified antigen, comb. with toxoids
boostrix polio inj.susp
glaxosmithkline ΜΟΝΟΠΡΟΣΩΠΗ ΑΝΩΝΥΜΗ ΕΜΠΟΡΙΚΗ ΚΑΙ ΒΙΟΜΗΧΑΝΙΚΗ ΕΤΑΙΡΕΙΑ ΦΑΡΜΑΚΕΥΤΙΚΩΝ ΠΡΟΪΟΝΤΩΝ Δ.Τ. glaxosmithkline ΜΟΝΟΠΡΟΣΩΠΗ Α.Ε.Β.Ε. Λεωφ. Κηφισίας 266,, 152 32 152 32, Χαλάνδρι 210-6882100 - diphtheria toxoid, adsorbed; tetanus toxoid; pertussis toxoid (pt); filamentous haemagglutinin (fha); pertactin (69 kda outer membrane protein-69k); inactivated poliovirus vacc type i; inactivated poliovirus vacc type ii; inactivated poliovirus vacc type iii - inj.susp (ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ) - diphtheria toxoid, adsorbed 0 => 2iu; tetanus toxoid 0 => 20iu; pertussis toxoid (pt) 8mcg; filamentous haemagglutinin (fha) 8mcg; pertactin (69 kda outer membrane protein-69k) 2,5mcg; inactivated poliovirus vacc type i 40du; inactivated poliovirus vacc type ii 8du; inactivated poliovirus vacc type iii 32du - diphtheria-pertussis-poliomyelitis-tetanus
tetravac (εμβολιο) inj.susp (1δοση)0,5ml pf.syr.
sanofi pasteur europe, france 14 espace henry vallee, 69007 lyon +33 437 28 40 00 - purified diphteria toxoid; purified tetanus toxoid; purified pertussis toxoid (pt xd); filamentous haemagglutinin (fha); inactivated poliovirus vacc type i; inactivated poliovirus vacc type ii; inactivated poliovirus vacc type iii - inj.susp (ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ) - (1ΔΟΣΗ)0,5ml pf.syr. - purified diphteria toxoid 20iu; purified tetanus toxoid 40iu; purified pertussis toxoid (pt xd) 25mcg; filamentous haemagglutinin (fha) 25mcg; inactivated poliovirus vacc type i 29du; inactivated poliovirus vacc type ii 7du; inactivated poliovirus vacc type iii 26du - diphtheria-pertussis-poliomyelitis-tetanus
repevax inj.su.pfs
sanofi pasteur europe, france 14 espace henry vallee, 69007 lyon +33 437 28 40 00 - diphtheria toxoid, adsorbed; tetanus toxoid, adsorbed; purified pertussis toxoid (pt xd); adsorbed purified filamentous haemagglutinin (fha); adsorbed purified pertactin (prn); adsorbed purified fimbrial agglutinogens 2+3 (fim); inactivated poliovirus vacc type i; inactivated poliovirus vacc type ii; inactivated poliovirus vacc type iii; aluminium phosphate - inj.su.pfs (ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ ΣΕ ΠΡΟΓΕΜΙΣΜΕΝΗ ΣΥΡΙΓΓΑ) - diphtheria toxoid, adsorbed 2iu; tetanus toxoid, adsorbed 20iu; purified pertussis toxoid (pt xd) 2,5mcg; adsorbed purified filamentous haemagglutinin (fha) 5mcg; adsorbed purified pertactin (prn) 3mcg; adsorbed purified fimbrial agglutinogens 2+3 (fim) 5mcg; inactivated poliovirus vacc type i 29u; inactivated poliovirus vacc type ii 7u; inactivated poliovirus vacc type iii 26u; aluminium phosphate 1,5mg - diphtheria-pertussis-poliomyelitis-tetanus
triaxis inj.su.pfs 0,5ml (1 dose)
sanofi pasteur europe, france 14 espace henry vallee, 69007 lyon +33 437 28 40 00 - diphtheria toxoid, adsorbed; tetanus toxoid, adsorbed; pertussis toxoid (pt); filamentous haemagglutinin (fha); pertactin (69 kda outer membrane protein-69k); fimbriae types 2 and 3 absorbed (fim); aluminium phosphate - inj.su.pfs (ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ ΣΕ ΠΡΟΓΕΜΙΣΜΕΝΗ ΣΥΡΙΓΓΑ) - 0,5ml (1 dose) - diphtheria toxoid, adsorbed 2iu; tetanus toxoid, adsorbed 20iu; pertussis toxoid (pt) 2,5mcg; filamentous haemagglutinin (fha) 5mcg; pertactin (69 kda outer membrane protein-69k) 3mcg; fimbriae types 2 and 3 absorbed (fim) 5mcg; aluminium phosphate 1,5mg - pertussis, purified antigen, comb. with toxoids
infanrix tetra inj.su.pfs 0,5ml/dose (pfs)
glaxosmithkline ΜΟΝΟΠΡΟΣΩΠΗ ΑΝΩΝΥΜΗ ΕΜΠΟΡΙΚΗ ΚΑΙ ΒΙΟΜΗΧΑΝΙΚΗ ΕΤΑΙΡΕΙΑ ΦΑΡΜΑΚΕΥΤΙΚΩΝ ΠΡΟΪΟΝΤΩΝ Δ.Τ. glaxosmithkline ΜΟΝΟΠΡΟΣΩΠΗ Α.Ε.Β.Ε. Λεωφ. Κηφισίας 266,, 152 32 152 32, Χαλάνδρι 210-6882100 - filamentous haemagglutinin (fha); pertactin (69 kda outer membrane protein-69k); pertussis toxoid (pt); diphtheria toxoid, adsorbed; tetanus toxoid; inactivated poliovirus vacc type i; inactivated poliovirus vacc type ii; inactivated poliovirus vacc type iii - inj.su.pfs (ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ ΣΕ ΠΡΟΓΕΜΙΣΜΕΝΗ ΣΥΡΙΓΓΑ) - 0,5ml/dose (pfs) - filamentous haemagglutinin (fha) 25; pertactin (69 kda outer membrane protein-69k) 8g; pertussis toxoid (pt) 25g; diphtheria toxoid, adsorbed 30iu; tetanus toxoid 40iu; inactivated poliovirus vacc type i 40du; inactivated poliovirus vacc type ii 8du; inactivated poliovirus vacc type iii 32du - diphtheria-pertussis-poliomyelitis-tetanus
boostrix 0,5ml/vial (1 dose) ενεσιμο εναιωρημα
glaxosmithkline aebe - ΔΙΦΘΕΡΙΤΙΚΉ ΑΝΑΤΟΞΊΝΗ, ΠΡΟΣΡΟΦΗΜΈΝΟ, ΤΟΞΟΕΙΔΈΣ ΤΟΥ ΤΕΤΆΝΟΥ, purified pertussis toxoid (pt xd), ΝΗΜΑΤΟΕΙΔΉ ΑΙΜΟΣΥΓΚΟΛΛΗΤΊΝΗ (fha), pertactin (69 kda outer membrane protein-69k) - ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ - 0,5ml/vial (1 dose) - ineof00157 - diphtheria toxoid, adsorbed - 0.000000 ; 8000040440 - tetanus toxoid - 0.000000 ; ineof01454 - purified pertussis toxoid (pt xd) - 8.000000 mcg; ineof01236 - filamentous haemagglutinin (fha) - 8.000000 mcg; ineof01237 - pertactin (69 kda outer membrane protein-69k) - 2.500000 mcg - pertussis, purified antigen, comb. with toxoids
tetravac inj.susp (1 dose) 0,5ml pf.syr
ΕΛΛΗΝΙΚΟ ΙΝΣΤΙΤΟΥΤΟ ΠΑΣΤΕΡ Βασ.Σοφίας 127,, 115 21 115 21, Αθήνα 6462281, 6430044 - purified diphteria toxoid; purified tetanus toxoid; purified pertussis toxoid (pt xd); filamentous haemagglutinin (fha); inactivated poliovirus vacc type i; inactivated poliovirus vacc type ii; inactivated poliovirus vacc type iii - inj.susp (ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ) - (1 dose) 0,5ml pf.syr - purified diphteria toxoid; purified tetanus toxoid; purified pertussis toxoid (pt xd); filamentous haemagglutinin (fha); inactivated poliovirus vacc type i; inactivated poliovirus vacc type ii; inactivated poliovirus vacc type iii - diphtheria-pertussis-poliomyelitis-tetanus